This post was originally published on this site
Abbott Labs announced earnings per share of $1.45 on revenue of $10.70B. Analysts polled by Investing.com anticipated EPS of $1.35 on revenue of $9.94B.
Abbott Labs shares are down 5% from the beginning of the year, still down 0.58% from its 52 week high of $115.40 set on January 25. They are under-performing the S&P 500 which is up 2.49% from the start of the year.
Abbott Labs shares gained 2.74% in pre-market trade following the report.
Abbott Labs’s report follows an earnings beat by J&J on Tuesday, who reported EPS of $1.86 on revenue of $22.48B, compared to forecasts EPS of $1.83 on revenue of $21.69B.
Novartis ADR had missed expectations on Tuesday with fourth quarter EPS of $1.34 on revenue of $12.77B, compared to forecast for EPS of $1.36 on revenue of $12.92B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
